Press releases

Genoskin appoints new board memberto strengthen governancePress releaseGenoskin Strengthens Governance with Appointment of Industry Leader Fabrice BouteilleA strategic milestone reinforcing independence, global growth, and leadership in human-relevant researchA new chapter in Genoskin’s growth journey Genoskin announces the appointment of Fabrice Bouteille as an independent member of its Board of Directors—marking a pivotal step in the company’s evolution following its $8.7Read more

Genoskin & argenx showcasehuman-based NAM platformPress releaseGenoskin presents translational human-based NAM platform at SOT 2026 in collaboration with argenxAdvancing New Approach Methodologies (NAMs) with human skin modelsAt the 2026 annual meeting of the Society Of Toxicology (SOT), we will present new data demonstrating the value of our HypoSkin® ex vivo human skin platform as a translational human-based New Approach MethodologyRead more

Genoskin raises $8.7M series Ato support drug development with ethical, human-based modelsFunding to accelerate global expansion and strengthen scientific leadership We are excited to announce that Genoskin, a leader in developing ex vivo human skin platforms for testing drugs and medical devices, has raised $8.7 million (€8M) in Series A funding. The investment will fuel the company’s global expansion, enhanceRead more

Research HighlightExplore our latest publication in Allergy: the story behind the idea and key findings.The landscape of vaccine research is undergoing an important transformation, thanks to the breakthroughs in mRNA vaccine technology. This innovation has catalyzed the development of vaccines that are not only highly effective but also rapidly deployable at a large scale. With the increasing number of researchRead more

PRESS RELEASE - Salem, MA, USA - October 3rd, 2023 Genoskin introduces ImmunoSafe: ISR Platform® with AUDACY - A revolutionary leap in non-clinical local toxicity assessment Salem, MA, October 3rd, 2023 - Genoskin, a biotechnology company at the forefront of accelerating drug development, proudly announces the enhancement of its ISR Platform® with the integration of AUDACY, a state-of-the-art bioinformatics-based analyticalRead more

PRESS RELEASE - Toulouse, France - June 8th, 2023 Introducing MANTIS®: A Breakthrough Analytic Pipeline for Unraveling the Complexity of Inflammatory Skin Conditions. Toulouse, France, June 8, 2023 - Genoskin is proud to announce the publication of a groundbreaking scientific article in Science Advances, introducing a new analytic pipeline called MANTIS® (Multiplexed Annotated Tissue Imaging System). The article, authored byRead more